Fundraising FoxHepquant
1 known investors
Find your way into Hepquant
Sign up to see every warm intro you have to Hepquant
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hepquant team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HepQuant develops noninvasive, blood-based quantitative tests that measure liver cell function and blood flow to assess liver health and disease severity. The tests are used by healthcare providers to manage patients with advanced liver disease and by drug developers in clinical trials.
Investors · 1
Frequently asked questions
- What does Hepquant do?
- HepQuant develops noninvasive, blood-based quantitative tests that measure liver cell function and blood flow to assess liver health and disease severity. The tests are used by healthcare providers to manage patients with advanced liver disease and by drug developers in clinical trials.
- Who are Hepquant's investors?
- Hepquant's investors include Colorado BioScience Association.